Melanin-concentrating hormone (MCH) has been reported to be involved in the regulation of feeding behaviour in rats and mice. Because many neuropeptides that influence ingestive behaviour also regulate reproductive function, the present study was designed to determine if central administration of MCH changes pulsatile secretion of luteinizing hormone (LH) in the rats. Wistar-Imamichi strain female rats were ovariectomized and implanted with oestradiol to produce a moderate inhibitory feedback effect on LH release. The effects of i.c.v. injections of MCH on LH release were examined in freely moving animals. Blood samples were collected every 6 min for 3 h through an indwelling cannula. After 1 h of sampling, MCH (0.1, 1 or 10 mg/animal) or vehicle (saline) was injected into the third cerebroventricle. Because MCH is also reported to affect the hypothalamo-pituitary-adrenal (HPA) axis, which in turn, can influence reproductive function, plasma corticosterone concentrations were determined in the same animals at 30-min intervals during the first and last hours and every 12 min during the second hour of the 3-h sampling period. When expressed as per cent changes, mean plasma LH concentrations after MCH administration were significantly lower in the animals injected with all doses of the peptide compared with vehicle-treated animals; LH pulse frequency was significantly lowered by 1 mg of MCH. Per cent changes in mean plasma corticosterone levels were not significantly affected by MCH administration. These results in oestradiol-treated ovariectomized rats indicate that central MCH is capable of inhibiting pulsatile LH secretion. We have previously shown that 48-h fasting suppresses pulsatile LH release in the presence of oestrogen. Take together, these results raise the possibility that MCH could play a role in mediating the suppression of LH secretion during periods of reduced nutrition.
Experimental protocols
suppresses gonadal activity (14) , and glucoprivation supOne week after OVX, E 2 implantation and brain surgery, blood samples presses luteinizing hormone (LH ) secretion, but stimulates (110 ml ) were collected from the freely moving conscious animals at 6-min feeding behaviour (15) . Noradrenergic neurones projecting intervals for 3 h beginning at 13.00 h through Silastic tubing that was inserted to the paraventricular nucleus stimulate feeding behaviour into the right atrium on the previous day. An equivalent volume of rat red and suppress LH secretion (16, 17) . Peptides involved in the blood cells taken from donor animals was suspended in heparinized saline and replaced through the cannula after the removal of each blood sample.
regulation of feeding behaviour are also closely associated Plasma was separated immediately, aliquotted for LH (50 ml ) and corticoswith the activity of reproductive axis. Leptin, a peptide that terone (0.5 ml ) assay, and stored at −30°C until assayed.
suppresses feeding, reverses suppression of LH secretion in MCH (Sigma) was dissolved in saline at a concentration of 0.1, 1 or fasted rats and ob/ob mice (18) (19) (20) . We have recently demon-10 mg/5 ml. After the first hour of blood sampling, 5 ml of MCH solution or strated that motilin, a gastrointestinal peptide, stimulates equal volume of the vehicle was slowly (1 ml/min) infused into the third ventricle with a microinjection pump ( EP-60, EICOM, Kyoto, Japan) through feeding and suppresses pulsatile LH release (21) .
an inner cannula inserted into the outer cannula. To determine if central MCH could play an inhibitory role of variation were 4.2% for 3.3 ng/ml and 11.4% for 1.5 ng/ml, respectively.
in the regulation of reproductive neuroendocrine function, Plasma corticosterone levels were determined by RIA, with synthetic corticosterone (Sigma) used as a reference standard. Rabbit anticorticosterone the present study investigated the acute effect of i.c.v. injection serum and tritiated corticosterone were purchased from Teikoku-Zoki ( Tokyo, of MCH on pulsatile LH secretion in freely moving female Japan) and Amersham ( Tokyo, Japan), respectively. The least detectable level rats. OVX rats chronically implanted with oestradiol were of corticosterone was 2.5 ng/ml for 5 ml of plasma sample. The intra-and used, since this oestrogen treatment enhances inhibitory effect interassay coefficients of variation were 5.6% for 51.5 ng/ml and 8.8% for of fasting and glucoprivation on LH release (15, 24) . We detected by the one-way anova followed by Fisher's least significant difference test.
Materials and methods Results
Animals and surgery Figure 1 shows profiles of plasma LH levels in the animals (Fig. 1) . The middle dose (1 mg) of MCH Products Co., Roanoke, VA, USA) with its tip located in the third cerebrovensignificantly (P<0.05) suppressed LH pulse frequency. LH tricle (0.8 mm posterior and 7.5 mm ventral to the bregma at the midline).
pulse amplitude was not significantly affected by any dose
The females were allowed to recover from brain surgery for 1 week before blood sampling.
of MCH. In the present study, central MCH at all doses significantly decreased mean LH concentrations in freely moving oestroin the saline-and MCH-injected groups. When expressed as percent changes, mean corticosterone levels were not significgen-treated OVX rats. None of the doses used in our study stimulated LH secretion. Because the intermediate dose (1 mg) antly altered by central administration of any doses of MCH (Fig. 2) .
of MCH significantly decreased LH pulse frequency, it raises the possibility that MCH may participate in suppressing mediate the action of leptin on reproductive activity during fasting (plasma leptin levels decrease) because MCH mRNA GnRH release during fasting. The increase in MCH gene expression detected after food deprivation or glucoprivation levels decrease with central leptin administration (30) , and leptin receptors have been found in the MCH-containing (4, 6) appears to be consistent with this notion. MCH may neurones in the lateral hypothalamus (31) . In support of this hypothesis, peripheral administration of leptin reverses fasting-induced suppression of LH secretion (18) . In the present study, central MCH did not produce a dosedependent decrease in LH secretion: The middle dose (1 mg) of MCH clearly suppressed pulsatile LH release, while the highest dose (10 mg) of the peptide had only a moderate action on LH release. This could be explained by the hypothesis proposed by De Meyts et al. (32) for why some hormones, such as growth hormone (GH ), produce a bellshaped dose-response curves. This hypothesis arose from their studies of the effects of GH on lipogenesis in rat adipocytes. According to their model, high doses of ligands prevent receptor dimerization events critical to specific physiological or cellular responses. When this model is applied to our results for the effects of MCH on LH secretion, high doses would produce responses that are blunted or even diminished. However, at physiologic ligand concentrations of MCH, the receptors would dimerize to generate specific physiological responses to regulate LH secretion.
In the present study, saline-injected controls did not show a significant increase in plasma corticosterone levels, because the blood samples were collected prior to the onset of daily afternoon corticosterone surge occurring around the lightsoff (19.00 h in our light schedule). The administration of any doses of MCH into the third ventricle did not significantly affect plasma corticosterone levels. This result may imply that the inhibition of LH release by MCH is not mediated by increase in CRH expression or activation of the HPA axis. It has been shown that environmental factors, such as physical stress or glucoprivation, activate the HPA axis and suppress GnRH/LH secretion through CRH (26, 33, 34) . Under the above-mentioned circumstances, CRH is released into the portal circulation as well as within the hypothalamic regions to suppress GnRH release. It is most likely that MCH inhibits GnRH/LH release via other mechanism than CRH release in the hypothalamus. The effects of MCH on the HPA axis are still controversial. The inhibitory action of MCH on HPA axis is reported in a previous study, in which i.c.v. injection of MCH to the lateral ventricle did not affect basal ACTH secretion but even suppressed stress-induced ACTH release in male rats (9) . On the other hand, Jezova et al. suggested that the administration of MCH into the lateral ventricle stimulated ACTH secretion and this response was blocked by CRH antiserum in the male rat (10) . The effect of central LH secretion are the nucleus of the solitary tract (NTS) in the medulla oblongata and/or paraventricular nucleus. These MCH on the HPA axis should be clarified in future studies.
The finding of an inhibitory action of MCH on LH release nuclei include projections of both MCH and a-MSH-containing neurones (2, 40, 41) and express MC4R mRNA (42). in the present study does not agree in concept with the previous report in which local injection of MCH into the Both the paraventricular nucleus and NTS have been proposed to play a key role in inducing feeding behaviour and preoptic area or median eminence increased plasma LH concentrations (23) . This inconsistency may be due to several suppressing GnRH/LH secretion through a noradrenergic pathway in fasted or glucoprived rats (14, 16, 17, 25, 43) . differences. The first is that different sites were used for the administration of MCH. In the study by Gonzalez et al. (23) , Therefore, the increased MCH release during fasting could act at the NTS and/or paraventricular nucleus to mediate the MCH was injected locally into the preoptic area or median eminence whereas we administered the peptide into the third fasting-induced suppression of GnRH/LH secretion. The arcuate nucleus, which is involved in ingestive behaviour and ventricle. Because MCH immunoreactive neurones have been found to project to the various brain regions in rats (2), reproductive functions, could also be a candidate for the action site of MCH to regulate food intake and LH secretion. MCH injected in the ventricular system may exert diverse actions on brain sites different from the previous study. In
The arcuate receives axonal projections from both MCHand a-MSH-containing neurones and this hypothalamic nucthis regard, the present study found that the highest dose of MCH exerted only a moderate inhibitory action on LH leus also expresses MC3R mRNA (2, 40, 44) . Further studies will be required to clarify the sites of action for MCH to release. Perhaps, a more broad action by the high dose of MCH may overcome the inhibitory effect of this peptide on suppress LH release.
In conclusion, i.c.v. administration of MCH suppresses LH secretion. It is possible that degraded peptide in the cerebroventricle has a different action from intact peptide.
LH secretion in the oestradiol-primed OVX rat, raising the possibility that central MCH plays an inhibitory role in the The second potential difference for the opposite effect (inhibitory and stimulatory) of MCH on LH release might be due regulation of reproductive axis. Considering the role of MCH in regulating feeding behaviour, MCH may partly mediate to the difference in oestrogen treatment. Gonzalez et al. (23) used OVX animals bearing single injection of oestrogen the suppression of LH secretion during fasting or undernutrition. (5 mg/animal ), which could induce LH surge when it followed by progesterone administration; our oestrogen treatment only exerts an inhibitory feedback effect on tonic LH secretionreceptors, has been suggested to affect LH secretion (37, 38) , the anaesthetized animal model may not be optimal for study Accepted 22 November 1999 of brain mechanisms regulating gonadotropin secretion. We have determined that our blood sampling system is free of stress and is suitable for evaluating pulsatile LH secretion References under various conditions (17, 25, 26, 29) . The fourth difference between the two studies may be related to the presence
